In vivo and in vitro effects of vortioxetine on molecules associated with neuroplasticity

Keyphrases

• Neuroplasticity 100%
• Vortioxetine 100%
• In Vitro Effect 100%
• Phosphorylation 62%
• Protein Level 62%
• GluA1 62%
• Arg3.1 37%
• Aged Mice 37%
• CaMKII 37%
• Cofilin 25%
• Actin Depolymerizing Factor 25%
• Ca2+ 12%
• Methyl 12%
• Brain Function 12%
• Amino 12%
• Aging 12%
• Threonine 12%
• Cognitive Impairment 12%
• Cultured Hippocampal Neurons 12%
• C-Fos 12%
• Molecular Targets 12%
• Cognitive Function 12%
• Transcript Level 12%
• Fluoxetine 12%
• Multimodal Antidepressants 12%
• Mood Disorders 12%
• Synaptosomes 12%
• Glutamate Neurotransmission 12%
• Cultured Neurons 12%
• Frontal Cortex 12%
• Activity-regulated Cytoskeleton-associated Protein 12%
• Age-associated 12%
• Spine Maturation 12%
• Rodent Studies 12%
• Neuroactive Steroids 12%
• Dendritic Branching 12%
• GluA1 Subunit 12%
• AMPA Receptor Phosphorylation 12%
• Abnormal Change 12%
• Dendritic Spines 12%

Neuroscience

• In Vivo 100%
• In Vitro 100%
• Neuroplasticity 100%
• Vortioxetine 100%
• Serine 62%
• Cofilin 25%
• Actin Depolymerizing Factor 25%
• Cognitive Function 12%
• Brain Function 12%
• Kinase 12%
• Cognitive Disorders 12%
• Frontal Lobe 12%
• Glutamic Acid 12%
• Antidepressant 12%
• Mood Disorder 12%
• Fluoxetine 12%
• Activity Regulated Cytoskeleton Associated Protein 12%
• AMPA Receptor 12%
• C-Fos 12%
• Synaptic Transmission 12%
• Threonine 12%
• Receptor Phosphorylation 12%
• Vertebral Column 12%
• Calmodulin 12%
• Synaptosome 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Vortioxetine 100%
• Serine 62%
• Cofilin 25%
• Actin Depolymerizing Factor 25%
• Calcium Ion 12%
• Phosphotransferase 12%
• Clinical Study 12%
• Glutamic Acid 12%
• Antidepressant 12%
• Molecular Target 12%
• Fluoxetine 12%
• Cognitive Defect 12%
• Mood Disorder 12%
• Activity Regulated Cytoskeleton Associated Protein 12%
• AMPA Receptor 12%
• Threonine 12%
• Calmodulin 12%